Stephen W. Borron, M.D., Named Medical Editor-In-Chief of ToxED

PHILADELPHIA - Elsevier, the leading publisher of scientific, technical and medical information announced today that, the Stephen W. Borron, M.D., has been named Medical Editor-in-Chief of ToxED (www.toxed.com/), an online clinical toxicology reference that provides clinicians with quick access to concise and comprehensive drug, poison and chemical information at the point-of-care.

ToxED, a Gold Standard/Elsevier (goldstandard.com/) product, is written by practicing clinical toxicologists and emergency medicine clinicians and overseen by an Editorial Board composed of leaders in clinical toxicology. ToxED provides emergency medicine clinicians and other healthcare practitioners poisoning and drug overdose information specifically designed for use in patient-care settings.

“Dr. Borron’s professional expertise in emergency medicine and his involvement in a variety of toxicology projects will bring a high level of practical clinical experience to this position,” said Karl Matuszewski, PharmD, MS, Vice President and Editor-in-Chief, Gold Standard/Elsevier. “We are looking forward to even greater innovation from ToxED.”

Dr. Borron is an Attending Physician in Emergency Medicine and Medical Toxicology at University Medical Center of El Paso in Texas, a Level-1 trauma center and university teaching hospital. In addition, Dr. Borron is Chief Medical Officer for SafetyCall International, a private poison control center providing 24-hour emergency call center support, post marketing surveillance, regulatory and general toxicology consulting support to the industry. He is also President and Chief Medical Officer at International Toxicology Consultants, LLC, a medical toxicology consulting firm providing regulatory and general toxicology consulting, contract clinical and laboratory research, litigation support and workplace disease investigation.

Dr. Borron is a Professor of Emergency Medicine and Medical Toxicology at Texas Tech University Health Science Center’s Paul L. Foster School of Medicine and Clinical Professor of Emergency Medicine (Surgery) and Director of Emergency Medicine Research at The University of Texas Health Science Center at San Antonio.

“I am truly looking forward to collaborating with the other professionals at ToxED to help continue the evolution of this essential product for clinicians,” Dr. Borron said. “No other toxicology source delivers comparable information in such an easy-to-navigate and access format.”

In addition, the Board of Trustees of the American Academy of Clinical Toxicology recently announced that Dr. Borron will be honored this year with the designation of “Fellow of the American Academy of Clinical Toxicology.” This is a prestigious award bestowed on members who have been Academy members at least four years and have demonstrated consistent outstanding service to the Academy as well as to the field of clinical toxicology.

In 2007, 2.5 million people were exposed to poisons - almost 1.3 million of these exposures occurred in children 5 years or younger - 27 percent required treatment in a healthcare facility and 1,500 were fatal, according to the American Association of Poison Control Centers. Poison Control centers receive a call every eight seconds, and children younger than 3 years were involved in 38.1% of exposures and 51.2% occurred in children younger than 6 years.

About Gold Standard/Elsevier

Based in Tampa, FL, Gold Standard/ELSEVIER uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/ELSEVIER solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Gold Standard/ELSEVIER, visit www.goldstandard.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai’s Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Tom Reller Director of Corp. Relations, Elsevier +1-212-462-1912 T.Reller@Elsevier.com

Source: Elsevier

Tom Reller, Director of Corp. Relations, Elsevier, +1-212-462-1912, T.Reller at Elsevier.com